Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response.

Ulrich Jäger; Michael Fridrik; Markus Zeitlinger; Daniel Heintel; Georg Hopfinger; Sonja Burgstaller; Christine Mannhalter; Wilhelm Oberaigner; Edit Porpaczy; Cathrin Skrabs; Christine Einberger; Johannes Drach; Markus Raderer; Alexander Gaiger; Monique Putman; Richard Greil

doi:10.3324/haematol.2011.059246

Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response.

Ulrich Jäger, Michael Fridrik, Markus Zeitlinger, Daniel Heintel, Georg Hopfinger (Co-author), Sonja Burgstaller, Christine Mannhalter, Wilhelm Oberaigner, Edit Porpaczy, Cathrin Skrabs, Christine Einberger, Johannes Drach, Markus Raderer, Alexander Gaiger, Monique Putman, Richard Greil (Last author)

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

88 Citations (Web of Science)

Original language	English
Pages (from-to)	1431-1438
Journal	HAEMATOLOGICA
Volume	97
Issue number	9
DOIs	https://doi.org/10.3324/haematol.2011.059246
Publication status	Published - 2012

Keywords

ANTI-CD20 MONOCLONAL-ANTIBODY
NON-HODGKINS-LYMPHOMA
MANTLE CELL LYMPHOMA
DETUDE DES LYMPHOMES
HIGH TUMOR BURDEN
PHASE-II
LOW-GRADE
MAINTENANCE
TRIAL
PHARMACOKINETICS

Access to Document

10.3324/haematol.2011.059246

Cite this

Jäger, U., Fridrik, M., Zeitlinger, M., Heintel, D., Hopfinger, G., Burgstaller, S., Mannhalter, C., Oberaigner, W., Porpaczy, E., Skrabs, C., Einberger, C., Drach, J., Raderer, M., Gaiger, A., Putman, M., & Greil, R. (2012). Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response. HAEMATOLOGICA , 97(9), 1431-1438. https://doi.org/10.3324/haematol.2011.059246

Jäger, Ulrich ; Fridrik, Michael ; Zeitlinger, Markus et al. / Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response. In: HAEMATOLOGICA 2012 ; Vol. 97, No. 9. pp. 1431-1438.

@article{98859bd8f4644da7bc53dfa2013e9604,

title = "Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response.",

keywords = "ANTI-CD20 MONOCLONAL-ANTIBODY, NON-HODGKINS-LYMPHOMA, MANTLE CELL LYMPHOMA, DETUDE DES LYMPHOMES, HIGH TUMOR BURDEN, PHASE-II, LOW-GRADE, MAINTENANCE, TRIAL, PHARMACOKINETICS",

author = "Ulrich J{\"a}ger and Michael Fridrik and Markus Zeitlinger and Daniel Heintel and Georg Hopfinger and Sonja Burgstaller and Christine Mannhalter and Wilhelm Oberaigner and Edit Porpaczy and Cathrin Skrabs and Christine Einberger and Johannes Drach and Markus Raderer and Alexander Gaiger and Monique Putman and Richard Greil",

note = "12Department of Internal Medicine III, Private Medical University of Salzburg, Austria ",

year = "2012",

doi = "10.3324/haematol.2011.059246",

language = "English",

volume = "97",

pages = "1431--1438",

journal = "HAEMATOLOGICA ",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "9",

}

Jäger, U, Fridrik, M, Zeitlinger, M, Heintel, D, Hopfinger, G, Burgstaller, S, Mannhalter, C, Oberaigner, W, Porpaczy, E, Skrabs, C, Einberger, C, Drach, J, Raderer, M, Gaiger, A, Putman, M & Greil, R 2012, 'Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response.', HAEMATOLOGICA , vol. 97, no. 9, pp. 1431-1438. https://doi.org/10.3324/haematol.2011.059246

Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response. / Jäger, Ulrich; Fridrik, Michael; Zeitlinger, Markus et al.
In: HAEMATOLOGICA , Vol. 97, No. 9, 2012, p. 1431-1438.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response.

AU - Jäger, Ulrich

AU - Fridrik, Michael

AU - Zeitlinger, Markus

AU - Heintel, Daniel

AU - Hopfinger, Georg

AU - Burgstaller, Sonja

AU - Mannhalter, Christine

AU - Oberaigner, Wilhelm

AU - Porpaczy, Edit

AU - Skrabs, Cathrin

AU - Einberger, Christine

AU - Drach, Johannes

AU - Raderer, Markus

AU - Gaiger, Alexander

AU - Putman, Monique

AU - Greil, Richard

N1 - 12Department of Internal Medicine III, Private Medical University of Salzburg, Austria

PY - 2012

Y1 - 2012

KW - ANTI-CD20 MONOCLONAL-ANTIBODY

KW - NON-HODGKINS-LYMPHOMA

KW - MANTLE CELL LYMPHOMA

KW - DETUDE DES LYMPHOMES

KW - HIGH TUMOR BURDEN

KW - PHASE-II

KW - LOW-GRADE

KW - MAINTENANCE

KW - TRIAL

KW - PHARMACOKINETICS

U2 - 10.3324/haematol.2011.059246

DO - 10.3324/haematol.2011.059246

M3 - Original Article

C2 - 22511498

SN - 0390-6078

VL - 97

SP - 1431

EP - 1438

JO - HAEMATOLOGICA

JF - HAEMATOLOGICA

IS - 9

ER -

Jäger U, Fridrik M, Zeitlinger M, Heintel D, Hopfinger G, Burgstaller S et al. Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response. HAEMATOLOGICA . 2012;97(9):1431-1438. doi: 10.3324/haematol.2011.059246